Full Press Release Details
WALTHAM, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences.
The Stifel 2022 Healthcare Conference being held November 15-16 in New York. Jon K. Snodgres, Chief Financial Officer, will participate in an analyst-led discussion on Wednesday, November 16, at 2:25 p.m. EST.
Stephens’ Annual Investment Conference being held November 15-17 in Nashville. Mr. Snodgres will participate in an analyst-led discussion on Thursday, November 17, at 2:00 p.m. EST.
A live webcast of the discussions will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.
About Repligen Corporation
Global Head of Investor Relations